Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Viruses ; 14(11)2022 11 17.
Artigo em Inglês | MEDLINE | ID: mdl-36423152

RESUMO

Since it was clearly established that HIV/AIDS predisposes to the infection, persistence or reactivation of latent viruses, the prevalence of human polyomaviruses (HPyVs) among HIV-1-infected patients and a possible correlation between HPyVs and HIV sero-status were investigated. PCR was performed to detect and quantify JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV DNA in the urine and plasma samples of 103 HIV-1-infected patients. Subsequently, NCCR, VP1 and MCPyV LT sequences were examined. In addition, for MCPyV, the expression of transcripts for the LT gene was investigated. JCPyV, BKPyV and MCPyV's presence was reported, whereas HPyV6, HPyV7 and QPyV were not detected in any sample. Co-infection patterns of JCPyV, BKPyV and MCPyV were found. Archetype-like NCCRs were observed with some point mutations in plasma samples positive for JCPyV and BKPyV. The VP1 region was found to be highly conserved among these subjects. LT did not show mutations causing stop codons, and LT transcripts were expressed in MCPyV positive samples. A significant correlation between HPyVs' detection and a low level of CD4+ was reported. In conclusion, HPyV6, HPyV7 and QPyV seem to not have a clinical relevance in HIV-1 patients, whereas further studies are warranted to define the clinical importance of JCPyV, BKPyV and MCPyV DNA detection in these subjects.


Assuntos
Líquidos Corporais , Soropositividade para HIV , HIV-1 , Poliomavírus das Células de Merkel , Polyomavirus , Humanos , HIV-1/genética , Plasma , Genômica
2.
PLoS Pathog ; 17(9): e1009878, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34473805

RESUMO

SARS-CoV-2 fine-tunes the interferon (IFN)-induced antiviral responses, which play a key role in preventing coronavirus disease 2019 (COVID-19) progression. Indeed, critically ill patients show an impaired type I IFN response accompanied by elevated inflammatory cytokine and chemokine levels, responsible for cell and tissue damage and associated multi-organ failure. Here, the early interaction between SARS-CoV-2 and immune cells was investigated by interrogating an in vitro human peripheral blood mononuclear cell (PBMC)-based experimental model. We found that, even in absence of a productive viral replication, the virus mediates a vigorous TLR7/8-dependent production of both type I and III IFNs and inflammatory cytokines and chemokines, known to contribute to the cytokine storm observed in COVID-19. Interestingly, we observed how virus-induced type I IFN secreted by PBMC enhances anti-viral response in infected lung epithelial cells, thus, inhibiting viral replication. This type I IFN was released by plasmacytoid dendritic cells (pDC) via an ACE-2-indipendent but Neuropilin-1-dependent mechanism. Viral sensing regulates pDC phenotype by inducing cell surface expression of PD-L1 marker, a feature of type I IFN producing cells. Coherently to what observed in vitro, asymptomatic SARS-CoV-2 infected subjects displayed a similar pDC phenotype associated to a very high serum type I IFN level and induction of anti-viral IFN-stimulated genes in PBMC. Conversely, hospitalized patients with severe COVID-19 display very low frequency of circulating pDC with an inflammatory phenotype and high levels of chemokines and pro-inflammatory cytokines in serum. This study further shed light on the early events resulting from the interaction between SARS-CoV-2 and immune cells occurring in vitro and confirmed ex vivo. These observations can improve our understanding on the contribution of pDC/type I IFN axis in the regulation of the anti-viral state in asymptomatic and severe COVID-19 patients.


Assuntos
COVID-19/imunologia , Células Dendríticas/classificação , Interferon Tipo I/metabolismo , SARS-CoV-2/imunologia , Adulto , Idoso de 80 Anos ou mais , Infecções Assintomáticas , Linhagem Celular Tumoral , Células Dendríticas/imunologia , Células Dendríticas/virologia , Células Epiteliais/citologia , Feminino , Hospitalização , Humanos , Interferon Tipo I/imunologia , Pulmão/citologia , Masculino , Pessoa de Meia-Idade , Neuropilina-1/metabolismo , Fenótipo , Índice de Gravidade de Doença , Receptor 7 Toll-Like/metabolismo
3.
Ecotoxicol Environ Saf ; 70(1): 121-6, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-17662387

RESUMO

The uptake of cadmium and zinc by Spirulina platensis was investigated using a laboratory culture of this cyanobacterium. The cells were treated with metal concentrations increasing from 0.5 to 2.0 mg L(-1), in order to evaluate their adsorption capacity and survival potential. Afterwards, the cytotoxicity of cell extracts bioaccumulating heavy metals was evaluated on cultured L929 mouse fibroblasts. Cadmium was removed with higher yield (84.0-88.7%) than zinc (54.5-68.0%) and the maximum specific removal of these metals was 1.82 and 2.60 mg g(-1), respectively. Cadmium bioaccumulating algal extracts caused higher cell mortality of L929 cells than zinc accumulating ones, with a clear dose-response trend. EC(50) estimated by Trimmed Spearman-Karber (TSK) method were 7.21 and 9.59cells mL(-1) for cadmium and zinc, respectively. The capability to accumulate heavy metals could have a remarkable importance for the utilization of algal species in human or animal feeding.


Assuntos
Cádmio/toxicidade , Misturas Complexas/toxicidade , Spirulina/química , Zinco/toxicidade , Adsorção , Animais , Cádmio/química , Cádmio/metabolismo , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Clorofila/metabolismo , Clorofila A , Camundongos , Spirulina/metabolismo , Zinco/química , Zinco/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA